Long Term Care Journal
Friday, August 10, 2018
FDA approves new treatment for a rare genetic disorder, Fabry disease - FDA Press Releases
FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
from Food and Drug Administration--Press Releases https://ift.tt/2AXABmc
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment